ePrime: Evaluation of Magnetic Resonance (MR) Imaging to Predict Neurodevelopmental Impairment in Preterm Infants
This trial is active, not recruiting.
|Sponsor||Imperial College London|
|Start date||April 2010|
|End date||June 2015|
|Trial size||625 participants|
|Trial identifier||NCT01049594, EudraCT 2009-011602-42, RP-PG-0707-10154|
Preterm infants face an uncertain future because premature birth often leads to problems with brain development and can cause cerebral palsy.
A trial needs to be done to see if Magnetic Resonance Imaging (MRI) helps families and professionals by predicting long term problems more accurately, allowing better targeting of care to children with problems and reassuring the parents of normal babies.
This programme will provide the evidence-base for the National Health System (NHS) policy on the use of magnetic resonance imaging of the brain for preterm infants.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
|London, United Kingdom||Barnet General Hospital||no longer recruiting|
|London, United Kingdom||Croydon University Hospital||no longer recruiting|
|London, United Kingdom||Ealing Hospital NHS Trust||no longer recruiting|
|London, United Kingdom||Epsom and St Helier University Hospital||no longer recruiting|
|London, United Kingdom||Guys & St Thomas NHS Trust Foundation||no longer recruiting|
|London, United Kingdom||Hillingdon Hopsital||no longer recruiting|
|London, United Kingdom||Kingston Hospital NHS Trust||no longer recruiting|
|London, United Kingdom||Northwick Park Hospital||no longer recruiting|
|London, United Kingdom||Queen Charlotte's & Chelsea Hospital||no longer recruiting|
|London, United Kingdom||St George's Healthcare NHS Trust||no longer recruiting|
|London, United Kingdom||St Marys Hospital||no longer recruiting|
|London, United Kingdom||West Middlesex University Hospital||no longer recruiting|
|Surrey, United Kingdom||St. Peter's Hospital||no longer recruiting|
Delivery at less than 33 completed weeks of gestation
This programme will provide the evidence-base for NHS policy on the use of magnetic resonance (MR) imaging of the brain for preterm infants.
time frame: 5 years
Male or female participants up to 33 weeks old.
Inclusion Criteria: -Delivery at less than 33 completed weeks of gestation, estimated from early fetal ultrasonographic measurements as recommended in the National Institute of Clinical Excellence Guidelines: Antenatal Care for the Healthy Woman Exclusion Criteria: - Prior MR imaging - Major Congenital Malformations - Presence of Metallic Implants
|Official title||Evaluation of MR Imaging to Predict Neurodevelopmental Impairment in Preterm Infants|
|Principal investigator||David Edwards|
|Description||The trial will determine very accurately how well MRI predicts long-term problems, and it will assess whether it makes parents more or less anxious about their babies, and whether they seek more or less help in the first couple of years after birth,and see if the total cost to the NHS is increased by using MRI. It will also check up if there is a better way to do ultrasound examinations, and do a survey to see how much MRI is used in the United Kingdon (UK) and whether hospitals think they could provide it. The core of the project is a study of preterm babies who will be referred to a specialist centre to have both ultrasound and MRI scans. Half the parents will be told the results of the MRI and half the parents the ultrasound. The programme will then ask them to fill in questionnaires or be interviewed about their stress levels and the amount of support they seek for their children until they are two years old, when the babies will be examined to see if MRI predicted their outcome accurately.|
Call for more information